147 related articles for article (PubMed ID: 32821685)
1. Assessment of single nucleotide polymorphisms associated with steroid-induced ocular hypertension.
Badrinarayanan L; Chitipothu S; Ramasubramanyan S; Sripriya S; Rishi P; Rishi E; George R; Lakshmi BS; Elchuri SV
Int J Ophthalmol; 2020; 13(8):1294-1305. PubMed ID: 32821685
[TBL] [Abstract][Full Text] [Related]
2. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
[TBL] [Abstract][Full Text] [Related]
3. Whole-genome sequencing unravels novel genetic determinants and regulatory pathways associated with triamcinolone acetonide-induced ocular hypertension.
Badrinarayanan L; Nagarajan H; Rishi P; Rishi E; George RJ; Chitipothu S
Mol Genet Genomics; 2023 Jan; 298(1):13-26. PubMed ID: 36222912
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
[TBL] [Abstract][Full Text] [Related]
5. Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension.
Choi W; Kim JD; Bae HW; Kim CY; Seong GJ; Kim M
Yonsei Med J; 2022 Sep; 63(9):850-855. PubMed ID: 36031785
[TBL] [Abstract][Full Text] [Related]
6. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
[No Abstract] [Full Text] [Related]
7. Endothelial loss following postoperative intracameral triamcinolone acetonide and subconjunctival dexamethasone injections.
Sali F; Aykut V; Kunbaz A; Durmus E; Hepokur M; Oguz H; Esen F
Cutan Ocul Toxicol; 2023 Dec; 42(4):237-242. PubMed ID: 37486313
[TBL] [Abstract][Full Text] [Related]
8. Subtenon Triamcinolone Acetonide Removal for Uncontrolled Ocular Hypertension After Posterior Subtenon Injection of Triamcinolone Acetonide.
Chan LW; Hsu WC; Hsieh YT
J Glaucoma; 2016 Mar; 25(3):e268-72. PubMed ID: 26950466
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
[TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure changes following topical ocular hypotensive medications washout.
Ho H; Daas A; Ho J; Alaghband P; Galvis EA; de Antonio Ramirez A; Grassi P; Lim R; Lim KS
Br J Ophthalmol; 2021 Feb; 105(2):205-209. PubMed ID: 32277009
[TBL] [Abstract][Full Text] [Related]
11. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
[TBL] [Abstract][Full Text] [Related]
12. Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation.
Choi W; Bae HW; Shin HJ; Kim EW; Kim CY; Kim M; Seong GJ
Br J Ophthalmol; 2022 Aug; 106(8):1150-1156. PubMed ID: 33737305
[TBL] [Abstract][Full Text] [Related]
13. Agreement of intraocular pressure measurement with Corvis ST, non-contact tonometer, and Goldmann applanation tonometer in children with ocular hypertension and related factors.
Li HG; Chen YH; Lin F; Li SY; Liu QH; Yin CG; Chen XY; Zhang XJ; Qu Y; Hui YN
Int J Ophthalmol; 2023; 16(10):1601-1607. PubMed ID: 37854370
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.
Hayreh SS; Zimmerman MB; Beri M; Podhajsky P
Ophthalmology; 2004 Jan; 111(1):133-41. PubMed ID: 14711725
[TBL] [Abstract][Full Text] [Related]
15. Control of steroid-induced glaucoma with surgical excision of sub-Tenon triamcinolone acetonide deposits: a clinical and biochemical approach.
Okka M; Bozkurt B; Kerimoglu H; Ozturk BT; Gunduz K; Yılmaz M; Okudan S
Can J Ophthalmol; 2010 Dec; 45(6):621-6. PubMed ID: 20935694
[TBL] [Abstract][Full Text] [Related]
16. The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema.
Cicinelli MV; Rosenblatt A; Grosso D; Zollet P; Capone L; Rabiolo A; Lattanzio R; Loewenstein A; Bandello F;
Eye (Lond); 2021 Dec; 35(12):3232-3242. PubMed ID: 33479485
[TBL] [Abstract][Full Text] [Related]
17. Ocular hypertension and its predictor after a single Ozurdex implant: One-year follow-up in Asian Indian eyes.
Mansoori T; Shiva S; Balakrishna N
Oman J Ophthalmol; 2022; 15(3):299-303. PubMed ID: 36760962
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure elevation following triamcinolone acetonide administration as related to administration routes.
Hirano Y; Ito T; Nozaki M; Yasukawa T; Sakurai E; Yoshida M; Ogura Y
Jpn J Ophthalmol; 2009 Sep; 53(5):519-22. PubMed ID: 19847609
[TBL] [Abstract][Full Text] [Related]
19. Identification of proteomic changes for dexamethasone-induced ocular hypertension using a tandem mass tag (TMT) approach.
Liang X; Li N; Rong Y; Wang J; Zhang H
Exp Eye Res; 2022 Mar; 216():108914. PubMed ID: 34979099
[TBL] [Abstract][Full Text] [Related]
20. [The efficiency of 23 G vitrectomy combined with preoperative subtenon injection of triamcinolone acetonide for treatment of retinal detachment associated with choroidal detachment].
Mao JB; Wu SL; Chen YQ; Dong YG; Zheng B; Tao JW; Zhao SX; Fang D; Shen LJ
Zhonghua Yan Ke Za Zhi; 2018 Apr; 54(4):252-257. PubMed ID: 29747353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
